Neurocrine Biosciences (NBIX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurocrine Biosciences (NBIX)

NBIX 145.52

-3.0%

10:51 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Xavier who wrote (96)	8/17/1998 3:44:00 PM
From: Patrick grogan	Read Replies (1) of 1834

Neurocrine Biosciences' Clinical Development Compound, IL-4 Fusion Toxin, Demonstrates Complete Regression of Malignant Brain Tumor in Preclinical Study biospace.com This is potentially huge, Entremed soared on similar information

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next